Department of Nursing Care, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Department of General Surgery, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
J Cancer Res Ther. 2022 Dec;18(7):1937-1944. doi: 10.4103/jcrt.jcrt_425_22.
Reminiscence therapy (RT) is frequently used with elderly patients to improve their psychological status, but a few studies have examined its application in lung cancer patients. This study explored whether a reminiscence therapy-involved care program (RTICP) could improve cognitive functions, anxiety, depression, patient satisfaction, and survival in elderly lung cancer patients.
This randomized, controlled study enrolled 138 elderly post-operative lung cancer patients into two groups, an RTICP group (n = 69) and a usual care program (UCP) group (n = 69), for a 12-month intervention period and a follow-up period. During the 12-month intervention, the Mini-Mental State Examination (MMSE) score, the Hospital Anxiety and Depression Scale for anxiety (HADS-A) and depression (HADS-D), patient satisfaction, disease-free survival (DFS), and overall survival (OS) were evaluated.
MMSE and patient satisfaction were elevated in the RTICP group compared to the UCP group at month (M) 12. Additionally, RTICP reduced HADS-A at M6, M9, and M12 and the anxiety rate at M9, HADS-D at M9, and M12 compared to UCP, whereas the depression rate was no different between the two groups at any time (all P > 0.050). Moreover, DFS and OS were no different between the two groups (all P > 0.050).
RTICP, considered as an optional psychological intervention, enhances cognitive functions, alleviates anxiety and depression feelings, and elevates satisfaction among elderly lung cancer patients.
回忆疗法(RT)常用于改善老年患者的心理状态,但很少有研究探讨其在肺癌患者中的应用。本研究旨在探讨回忆疗法参与的护理方案(RTICP)是否能改善老年肺癌患者的认知功能、焦虑、抑郁、患者满意度和生存情况。
本随机对照研究纳入了 138 名老年术后肺癌患者,分为 RTICP 组(n=69)和常规护理方案(UCP)组(n=69),干预期为 12 个月,随访期为 12 个月。在 12 个月的干预期间,评估了简易精神状态检查(MMSE)评分、医院焦虑抑郁量表(HADS-A 和 HADS-D)用于评估焦虑和抑郁、患者满意度、无病生存期(DFS)和总生存期(OS)。
与 UCP 组相比,RTICP 组在第 12 个月时 MMSE 和患者满意度均升高。此外,与 UCP 组相比,RTICP 组在第 6、9 和 12 个月时 HADS-A 降低,第 9 个月时焦虑率降低,第 9 和 12 个月时 HADS-D 降低,而两组之间任何时间点的抑郁率均无差异(均 P>0.050)。此外,两组之间的 DFS 和 OS 均无差异(均 P>0.050)。
RTICP 作为一种可选的心理干预措施,可以增强老年肺癌患者的认知功能,减轻焦虑和抑郁情绪,提高患者满意度。